Developing and Commercializing Diagnostic Tests for Unmet Clinical Needs

Saving Lives Through Early Disease Diagnosis

Miraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. 

Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.

Our lead medical device programs are the PreVu Non-Invasive Skin Cholesterol Point-of-Care (POC) Test and the Scout DS Non-Invasive Diabetes Screening Test.

The Miraculins Advantage

Products & Programs

Miraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.

Research & Technology

Miraculins is focused on acquiring diagnostic technologies that have gone through early research and discovery stages at the university or research institution level, but are not yet ready for commercialization.  The Company adds value by developing the technology into clinical grade quality and by driving it through regulatory approval and ultimately to sales.

Miraculins Lead Technologies

To go directly to the PreVu web site, please click here: Click here to the visit the PreVu web site.

To go directly to the Scout DS web site, please click here: Miraculins Scout DS